New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base - solution for injection - 0.05 mg/ml - active: octreotide acetate 0.056 mg/ml equivalent to 0.05 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 0.112 mg/ml equivalent to 0.1 mg/ml octreotide base - solution for injection - 0.1 mg/ml - active: octreotide acetate 0.112 mg/ml equivalent to 0.1 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - octreotide acetate 0.56 mg/ml equivalent to 0.5 mg/ml octreotide base - solution for injection - 0.5 mg/ml - active: octreotide acetate 0.56 mg/ml equivalent to 0.5 mg/ml octreotide base excipient: lactic acid mannitol sodium bicarbonate water for injection

Malta - Inggeris - Medicines Authority

novartis pharmaceuticals uk limited - octreotide 0.5 mg/ml - solution for infusion or injection

Malta - Inggeris - Medicines Authority

novartis pharmaceuticals uk limited - octreotide 0.2 mg/ml - solution for infusion or injection

Malta - Inggeris - Medicines Authority

novartis pharmaceuticals uk limited - octreotide 10 mg - powder and solvent for suspension for injection

Malta - Inggeris - Medicines Authority

novartis pharmaceuticals uk limited - octreotide 20 mg - powder and solvent for suspension for injection

Malta - Inggeris - Medicines Authority

novartis pharmaceuticals uk limited - octreotide 30 mg - powder and solvent for suspension for injection

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - octreotide -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - octreotide -